Amazon has officially stepped deeper into the booming weight-loss drug market, launching a new GLP-1 treatment program designed to make obesity care faster, more convenient, and more accessible for patients.

Hong Kong police and health officials have arrested five individuals following a series of raids on local pharmacies, uncovering a massive haul of anti-obesity medications and other dangerous drugs.

Eli Lilly is looking to position India as a key hub in its global supply chain as sales of its blockbuster weight-loss drug Mounjaro surge in the country.

Novo Nordisk and Eli Lilly are lowering the prices of their leading obesity drugs, Wegovy and Mounjaro, in China, according to the Danish company and Chinese drug suppliers.

Novo Nordisk’s stock surged after the U.S. Food and Drug Administration approved the drugmaker’s weight-loss pill, giving the Danish company a boost in the competitive race to bring an effective oral obesity treatment to market and helping it regain momentum against rival Eli Lilly.